Bertamini L, Zihala D, Kostopoulos I, D’Agostino M, Martín-Sánchez E, Garcés Latre J, Hofste Op Bruinink D, Puig N, Zweegman S, Bertuglia G, Malandrakis P, Sevcikova T, Cupedo T, Van De Donk N, Cedena M, Musto P, Ntanasis-Stathopoulos I, Venglar O, Van Duin M, Lahuerta J, Rota Scalabrini D, Tsitsilonis O, Popkova T, Blade J, Zamagni E, Gavriatopoulou M, Muronova L, Van Der Holt B, Moreau P, Mateos M, Galli M, Katodritou E, Stork M, Belotti A, Rousakis P, Borsky M, Corre J, Boccadoro M, Dimopoulos M, Hajek R, San Miguel J, Sonneveld P, Gay F, Terpos E, Broijl A, Paiva B, Jelinek T. B04 | BLOOD-BASED RISK STRATIFICATION OF MYELOMA PATIENTS USING CIRCULATING TUMOR CELLS: RESULTS FROM THE EUROPEAN CTC CONSORTIUM. haematol [Internet]. 2026Apr.15 [cited 2026Apr.21];111(s2). Available from: https://haematologica.org/article/view/haematol.2026.s2.14103